Needle-Free Injection System Market Report | Share, Growth & Size 2028
[研究报告]无针注射系统市场预计将从2021年的1.3164亿美元增长到2028年的4.1131亿美元;预计2022年至2028年的复合年增长率为17.7 %。
市场洞察和分析师观点:
无针注射系统是一种无需使用传统针头即可将药物或疫苗注射到体内的医疗设备。该系统不刺穿皮肤,而是使用高压技术将药物强行通过皮肤并进入下层组织。这种方法通常受到害怕针头和对注射感到焦虑的患者青睐。无针注射系统还用于传统针头可能造成感染或伤害风险的情况。无针注射装置利用压力通过皮肤输送药物,无需使用传统针头。这可以让患者更舒适,并降低 医护人员被针刺伤的风险。
对无针注射系统市场产生积极影响的因素包括患者需求的不断增长以及全球范围内治疗的推广,这推动了对无针注射系统的需求。此外,无针注射系统市场的技术进步不断提高,政府改善医疗保健的举措也不断增加。尽管无针注射装置具有潜在的优势,但一些限制因素可能会影响市场。一个主要制约因素是开发和制造这些装置的成本。与传统的基于针的方法相比,无针注射技术的生产可能更复杂、更昂贵,这可能会限制某些患者和医疗保健提供者获得这些技术。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
无针注射系统市场:
复合年增长率(2021 - 2028 年)17.7%- 2021 年市场规模
1.3164 亿美元 - 市场规模 2028 年
4.1131 亿美元
市场动态
- 患者患病率不断上升,促进治疗以促进市场增长
- 研究与开发能力
- 制造商的战略活动
- 无痛给药需求不断增长
关键人物;主力;重要一员
- 交叉学科
- INOVIO 制药公司
- 新西兰制药公司
- 医药喷气
- 门户仪器
- 医疗国际技术公司(麻省理工学院加拿大)
- NuGen 医疗设备
- 费林公司
- 国家医疗产品有限公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 液体无针注射器
- 弹丸式/储库式无针注射器
- 粉末无针注射器
- 可填充无针注射器
- 预充式无针注射器
- 喷射式无针注射器
- Spring Global 无针注射器
- 激光无针注射器
- 基于振动的无针注射器
- 一次性无针注射器
- 可重复使用的无针注射器
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
增长动力:
无针注射系统的一个主要推动因素是提高患者的舒适度和依从性。许多患者,尤其是儿童和有针头恐惧症的患者,在面对传统针头注射时会感到焦虑和恐惧。通过提供无针替代产品,医疗保健提供者可以提高用户/患者的满意度和对治疗计划的依从性。另一个推动因素是有可能降低医护人员针刺伤和相关污染的风险。针刺伤可能导致严重的健康风险,包括传播 HIV 和肝炎等血源性病原体。通过消除对针头的需求,无针注射系统可以帮助保护医护人员免受这些职业危害。
此外,无针注射系统可以实现更精确、更一致的药物输送。这些系统中的高压技术可以确保药物以正确的深度和适当的力度输送,从而改善治疗效果。总体而言,无针注射系统的推动力来自于改善患者舒适度、增强医护人员安全性以及优化药物和疫苗输送的愿望。随着技术的进步,无针注射系统的开发和采用有望在医疗保健行业中增长。
机会:
对更方便、侵入性更小的药物输送方法的需求不断增长,这为无针注射市场提供了重大机遇。无针注射装置为传统注射提供了一种无痛、方便的替代方案,使患者更容易坚持用药方案。这些装置使用喷射注射器或微针等技术来无针输送药物,为患者提供更舒适的体验。这可以提高药物依从性和患者治疗效果,尤其是对于需要频繁注射的慢性病患者。此外,无针注射装置有助于减少针刺伤和血源性感染传播的机会,使其成为患者和医疗保健提供者的更安全选择。随着对更方便、更有效的药物输送方法的需求不断增长,无针注射市场具有扩大的潜力,并提供创新的解决方案来满足患者和医疗保健提供者的需求。这为医疗保健行业的运营公司提供了一个重大机遇,可以开发和商业化可以对患者护理和治疗结果产生积极影响的无针注射装置。
报告细分和范围:
“无针注射系统市场”根据类型、产品、技术、可用性、交付地点、应用、最终用户和地理位置进行细分。根据类型,市场细分为液体无针注射器、弹丸/储库无针注射器、粉末无针注射器。在产品方面,无针注射系统市场细分为可填充无针注射器和预填充无针注射器。根据技术,市场分为喷射式无针注射器、弹簧全局无针注射器、激光供电无针注射器、振动无针注射器。根据可用性,市场细分为一次性无针注射器和可重复使用无针注射器。根据交付地点,市场细分为皮下注射器、肌肉内注射器和皮内注射器。在应用方面,无针注射系统市场细分为疫苗输送、胰岛素输送、肿瘤学、疼痛管理等。根据最终用户,市场细分为医院和诊所、家庭护理机构、研究实验室、制药和生物技术公司等。根据地域,无针注射系统市场细分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、西班牙和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
节段分析:
根据类型,市场细分为液体无针注射器、弹丸/储库无针注射器和粉末无针注射器。液体无针注射器细分市场在 2022 年占据了最大的市场份额,预计在 2022-2030 年期间将实现市场最高复合年增长率。液体无针注射市场的一个主要驱动因素是对更方便、更少痛苦的药物输送方法的需求不断增长。患者越来越多地寻求传统针头注射的替代品,而液体无针注射系统提供了一种更舒适、侵入性更小的选择。另一个驱动因素是提高药物依从性和患者预后的潜力。液体无针注射系统可以提供更精确、更一致的药物输送,从而提高治疗效果和患者满意度。
此外,慢性病发病率和患病率的不断上升以及定期用药的需求推动了对更方便用户的注射方法的需求。液体无针注射系统可以帮助患者和医疗保健提供者更有效地管理慢性病。此外,对降低医疗成本和提高效率的关注推动了液体无针注射系统的采用。这些系统可以帮助最大限度地降低针刺伤的风险和相关的医疗成本,并减少对一次性针头和注射器的需求。总体而言,液体无针注射市场是由对更方便、更安全、更有效的药物剂量输送方法的需求以及改善患者治疗效果和降低医疗成本的需求所驱动的。因此,预计这些系统的市场将在未来几年继续增长。
区域分析:
根据地理位置,无针注射系统市场分为五个主要区域:北美、欧洲、亚太地区、南美和中美以及中东和非洲。北美很可能在 2022 年占据全球无针注射系统市场的很大份额。该地区的市场增长归因于对微创手术的需求不断增长、技术进步不断提高以及对患者安全的日益关注。糖尿病、高血压和哮喘等慢性病的发病率和患病率较高,导致对定期用药的需求增加。许多这些情况需要每日或频繁服用药物来控制症状和预防并发症。因此,对更方便、侵入性更小的药物输送方法的需求日益增长,使患者更容易遵守规定的治疗方案。传统的药物剂量输送方法,如口服片剂或注射剂,对患者来说可能很麻烦且很痛苦,导致依从性差和治疗效果不佳。因此,需要创新的药物输送技术,为患者提供更方便、更舒适的体验。
此外,慢性病的增多也给医疗保健系统和资源带来了负担,导致人们将重点放在降低医疗成本和提高效率上。通过更有效的药物输送方法提高服药依从性和患者治疗效果,医疗保健提供者可以减轻各种慢性病的负担并降低总体医疗成本。总体而言,慢性病的日益流行和定期服药的需求强烈要求更方便、更安全、更有效的药物输送方法,例如无针注射系统,它可以提高患者的依从性和治疗效果。这些都是北美国家(包括美国、加拿大和墨西哥)增加无针注射系统使用量的主要因素。
此外,美国每年确诊的糖尿病病例约为 140 万例。根据美国疾病控制与预防中心的数据,2020 年,约有 8800 万成年人患有糖尿病前期,占美国成年人口的 34.5%。根据加拿大糖尿病协会的数据,2022 年,该国糖尿病的患病率不断上升,报告的糖尿病或糖尿病前期病例为 1170 万例。根据同一消息来源,约有 570 万加拿大人被诊断患有糖尿病。根据加拿大统计局的数据,加拿大的生育率很低,从 2019 年每名妇女生育 1.47 个孩子下降到 2020 年每名妇女生育 1.40 个孩子。根据加拿大卫生信息研究所的数据,2022 年 7 月,约有 240 万人被诊断患有心脏病。这是加拿大继癌症之后的第二大死亡原因。过去几年,对微创手术的需求显着增加,以减轻与各种慢性疾病相关的负担。
无针注射系统市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 1.3164亿美元 |
2028 年市场规模 | 4.1131亿美元 |
全球复合年增长率(2021 - 2028) | 17.7% |
历史数据 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
行业发展和未来机遇:
以下列出了全球无针注射系统市场主要参与者采取的各种举措:
- 2023 年 11 月,美光生物医学公司获得资金,用于生产无针疫苗。这种疫苗注射无痛,通过将微阵列技术应用于皮肤并按下按钮即可给药。
- 2022 年 6 月,NovaXS 推出了其专利的“Telosis 技术”,可在 0.3 秒内无需针头注射细流药物,从而做出更明智的健康决策。
- 2022 年 12 月,Prejex Inc. 宣布与 Polybond 达成协议,生产无针注射器。
- 2020 年 11 月,领先的无针注射设备制造商 PharmaJet 宣布与全球制药公司 Mundipharma 建立战略合作伙伴关系。此次合作旨在扩大 PharmaJet 无针注射技术在疫苗和药物注射中的应用范围。
竞争格局和重点公司:
PharmaJet、Portal Instruments、Medical International Technology, Inc.、NuGen Medical Devices、Crossject SA、Antares Pharma、3M、Injex Pharma AG、NovaXS Biotech、INVIO Pharmaceutical Inc. 是主要的无针注射系统公司。这些公司专注于新技术、现有产品的改进和地域扩张,以满足全球日益增长的消费者需求。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The needle free injection system market is expected to be valued at US$ 411,312.81 thousands in 2028.
The fillable needle-free injectors segment held the largest share of the market in the global needle free injection system market contributing a market share of 63.6% in 2021.
Needle-free injection system is a jet injector that delivers medicine to intramuscular and subcutaneous tissue depths without needles. Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, advantages of drug delivery technology, increasing demand for self-injection devices.
The Needle Free Injection System market is estimated to be valued at US$ 131,640.54 thousands in 2021.
The CAGR value of the needle free injection system market during the forecasted period of 2022-2028 is 17.7%
The Needle Free Injection System market majorly consists of the players, such as Crossject; INOVIO Pharmaceuticals; Zealand Pharma A/S; PharmaJet; Portal Instruments; Medical International Technologies (MIT Canada) Inc.; NuGen Medical Devices; Ferring B.V.; National Medical Products, Inc.; and Aijex Pharma International Inc. among others.
The factors that are driving the growth of the needle free injection system market are increasing incidence of communicable diseases due to needlestick injuries and rising demand for self-injection devices are the major factors contributing to the growth of the Needle Free Injection System industry.
The Asia Pacific is expected to be the fastest-growing region in the needle free injection system market over the forecast period due to growing investments from international players in China and India, improving government support in countries, collaboration of research organizations, and advancing healthcare infrastructure.
The List of Companies - Needle Free Injector System Market
- Crossject
- INOVIO Pharmaceuticals
- Zealand Pharma A/S
- PharmaJet
- Portal Instruments
- Medical International Technologies (MIT Canada) Inc.
- NuGen Medical Devices
- Ferring B.V.
- National Medical Products, Inc.
- Aijex Pharma International Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.